Example: Heart Attack

Search clinical trials for: Lopinavir

Total 252 results

NCT00665951

Completed

Pharmacokinetic Study of Two Generic Co-formulations of Lopinavir/Ritonavir for HIV Infected Children (SURF)

Conditions: HIV Infections
NCT00771498

Completed

An Evaluation of the Pharmacological Interaction of Lopinavir/r and Rifampin

Conditions: HIV Infection, Tuberculosis
NCT00605098

Completed

Pharmacokinetics of the Tablet Formulation of Lopinavir/r as Standard and Increased Dosage During Pregnancy

Conditions: HIV Infections, Pregnancy
NCT02671383

Completed

Evaluation of Low-dose Darunavir in a Switch Study

Conditions: HIV Infections
NCT04364022

Completed

Efficacy of Pragmatic Same-day COVID-19 Ring Prophylaxis for Adult Individuals Exposed to SARS-CoV-2 in Switzerland

Conditions: Prevention of COVID-19
NCT04321174

Recruiting

COVID-19 Ring-based Prevention Trial With Lopinavir/Ritonavir

Conditions: Coronavirus Infections, Post-exposure Prophylaxis
NCT01172535

Completed

A Phase II/III Trial of Lopinavir/Ritonavir Dosed According to the WHO Pediatric Weight Band Dosing Guidelines

Conditions: HIV
NCT01255371

Withdrawn

A Multicentre Trial of Second-line Antiretroviral Treatment Strategies in African Adults Using Atazanavir or Lopinavir/Ritonavir

Conditions: HIV
NCT01139905

Completed

Lopinavir/Ritonavir (LPV/r) Tablet in HIV Infected Children

Conditions: HIV-1 Infections
NCT01095094

Terminated

Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade Glioma

Conditions: Brain Tumor, Anaplastic Astrocytoma, Anaplastic Ependymoma, Anaplastic Oligodendroglioma, Brain Stem Glioma, Giant Cell Glioblastoma, Glioblastoma, Gliosarcoma, Mixed Glioma
NCT00648999

Completed

Safety and Efficacy of Kaletra in ARV Therapy Experienced Patients

Conditions: Human Immunodeficiency Virus
NCT00234975

Completed

Safety of Lopinavir/Ritonavir (Kaletra) in HIV/HCV Co-infected Subjects vs Baseline Liver Biopsy Metavir Score

Conditions: HIV Infection
NCT00234962

Terminated

Study of Adherence Effects and Clinical Outcomes of Kaletra Based HIV Antiviral Therapy

Conditions: HIV Infection
NCT00344487

Terminated

Pilot Study of Effect of Kaletra on CD4 Response in HIV Positive (+) Patients With Viral Suppression KIMBO Study

Conditions: HIV
NCT00985543

Completed

Pharmacokinetics of Lopinavir/Ritonavir at Three Different Doses.

Conditions: Acquired Immunodeficiency Syndrome
NCT00160849

Completed

Lopinavir/r Monotherapy as Maintenance Therapy After Long Term Viral Suppression

Conditions: HIV Infections
NCT00102986

Completed

Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women

Conditions: HIV Infections
NCT00038480

Completed

Safety and Effectiveness of Lopinavir/Ritonavir in HIV Infected Infants

Conditions: HIV Infections
NCT00833378

Completed

Drug Interaction Study Between Eltrombopag and Lopinavir/Ritonavir in Healthy Adult Subjects.

Conditions: Hepatitis C
NCT00122226

Unknown status

MEDICLAS Study (Metabolic Effects of Different Classes of AntiretroviralS)

Conditions: HIV Infections, HIV-Associated Lipodystrophy Syndrome
NCT02581202

Completed

The Effectiveness of Dual Therapy (Lopinavir/Ritonavir + LamivudinE) in Treatment-Experienced HIV Infected Patients in the Russian Federation

Conditions: HIV-1 Infection
NCT04386070

Not yet recruiting

Preventing Pulmonary Complications in Surgical Patients at Risk of COVID-19

Conditions: Pulmonary Complications in Surgical Patients, COVID, Severe Acute Respiratory Syndrome
NCT00564772

Completed

Raltegravir Kaletra Pharmacokinetics

Conditions: Healthy
NCT00621166

Completed

Pharmacokinetics of Generic Lopinavir/Ritonavir in Pregnant Women

Conditions: HIV Infections
NCT01854762

Unknown status

Antiretroviral Regimens Containing Raltegravir for Prophylaxis of Mother-to-child-transmission of HIV Infection

Conditions: HIV, Pregnancy